For patients with matched primary breast cancer and malignant lymph nodes (panels b, c) or extracranial metastases (panels d, e), HER2 expression concordance was plotted across the HER2-null/-low/-positive and -null/-detectable spectra as per Fig. 1. The gene discussed is ERBB2; the disease is breast carcinoma.